On Tuesday, Shares of Alcatel Lucent SA (ADR) (NYSE:ALU), lost -1.99% to $3.94.
Nuage Networks, the Alcatel-Lucent, venture focused on software-defined networking (SDN) solutions, declared recently that Century Link, Inc. (CTL) has selected its technology to provide networking functionality for Century Link’s Programmable Services Backbone (PSB) network architecture.
PSB is an open, software-enabled platform for delivering dedicated services based on NFV technology to Century Link’s enterprise and small and mid-sized business (SMB) customers at any time regardless of their location. It places applications and services close to the network edge so they can be deployed, modified and scaled rapidly as business demands change. Century Link was one of the first providers to use NFV to deploy firewalls and content distribution networks. The company recently declared that, in the coming months, it anticipates to start deploying a range of virtualized data and voice infrastructure services, counting customer premises endpoints.
“By moving virtualized network functions from a hardware appliance to a pure software environment coordinated by Open Stack and Nuage Networks, Century Link will be able to automate provisioning with a policy-based approach,” Nuage Networks Chief Executive Officer Sunil Khandekar said. “It allows Century Link to develop, launch and perfect virtualized network services rapidly.”
Alcatel-Lucent provides Internet protocol (IP) and cloud networking, and ultra- broadband access worldwide. The company’s Core Networking segment offers IP routing, carrier Ethernet, network functions virtualization, and software defined networking applications and infrastructure to meet the challenges of network traffic growth while supporting the delivery of cloud-enabled business, mobile, and residential services for service providers, mobile network operators, cable/multiple system operators, transportation, utilities, and large-scale enterprises.
Shares of Avago Technologies Ltd (NASDAQ:AVGO), declined -5.25% to $119.86, during its last trading session.
Avago Technologies Limited, declared that, at its shareholder meeting held earlier recently, its shareholders have voted overwhelmingly to approve their formerly declared business combination transaction with Broadcom Corporation, with over 99% of the votes cast by Avago shareholders voted in favor of the transaction.
Avago and Broadcom declared their merger agreement on May 28, 2015. The companies have received clearance on their projected merger from the Committee on Foreign Investments in the United States and antitrust authorities in the United States, Japan and Taiwan. Among other customary conditions to closing, the transaction remains subject to regulatory approvals from the European Commission and antitrust authorities in China and South Korea, all of which are progressing. Avago presently anticipates that these remaining approvals will be received and anticipates the transaction to close late in calendar year 2015 or early in 2016.
Avago Technologies Limited designs, develops, and supplies semiconductor devices with a focus on analog III-V based products. The company operates through four segments: Wireless Communications, Wired Infrastructure, Enterprise Storage, and Industrial & Other segments.
Finally, Shares of Intrexon Corp (NYSE:XON), ended its last trade with 7.47% gain, and closed at $42.75.
Intrexon Corporation (XON), a leader in synthetic biology, recently declared its third quarter results for 2015.
Third Quarter Financial Highlights:
- Total revenues of $53.4 million, an improvement of 152% over the third quarter of 2014;
- Net loss of $38.2 million attributable to Intrexon, or $(0.34) per basic share;
- Adjusted EBITDA of $3.8 million, or $0.03 per basic share;
- Cash consideration received for reimbursement of research and development services covered 59% of cash operating expenses (exclusive of operating expenses of merged auxiliaries); and
- Cash, cash equivalents, and short-term and long-term investments totaled $352.6 million, and the value of equity securities totaled $76.6 million at September 30, 2015.
Intrexon Corporation, a biotechnology company, operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that comprise of key genetic components.